Current position

BlackRock, Inc.’s Elevance Health Inc Formerly (ANTM) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

BlackRock, Inc.Verified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ3 2016Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares23.50MHighest verified quarter-end share count
Quarters reported40Verified quarters with shares above zero
What happened?

BlackRock, Inc. first reported Elevance Health Inc Formerly in Q3 2016. The reported position was increased and reduced across later filings. BlackRock, Inc. currently reports 18.99M shares. The latest verified filing showed: Sold 4.5% of the position.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
Sold 4.5% of the position−896.02K shares · 18.99M shares remained
Filing context

Quarter-end price $386.73

Q1 2026
Baseline
Filing context

Quarter-end price $292.75

Q4 2025
Sold 0.6% of the position−130.64K shares · 20.40M shares remained
Filing context

Quarter-end price $350.55

Q3 2025
Bought 0.6% more+120.57K shares · 20.53M shares reported after the change
Filing context

Quarter-end price $323.12

Q2 2025
Sold 4.2% of the position−898.31K shares · 20.41M shares remained
Filing context

Quarter-end price $388.96

Q1 2025
Bought 4.3% more+868.83K shares · 21.31M shares reported after the change
Filing context

Quarter-end price $434.96

Portfolio importance

How important is Elevance Health Inc Formerly in BlackRock, Inc.’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight0.1%Q2 2026
Current rank#141of 5696 reported positions
Peak portfolio weight0.3%Q4 2022
Best historical rank#46Q4 2022
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest filing quarter-end price$386.73Q2 2026

Derived from validated reported value and shares where supported.

Latest verified investor filingQ2 2026 · filed 2026-08-07
Open SEC filing ↗

Coverage is bounded to BlackRock’s top reported positions and material events rather than every security in each Form 13F. Source filings may contain additional securities, and 13F filings do not reveal exact trade dates or execution prices.